6 projets européens trouvés
Recherche sur 125080 projets européens
TERMINÉ
Molecule-to-man pain network (PAIN-Net)
Date du début: 1 févr. 2017, Date de fin: 31 janv. 2021,
Neuropathic pain affects 5% of the general population and 40% of patients with neurological diseases, and has a key role in the pathophysiology of cancer pain that affects up to 50% of patients in the early disease stage and 30% of survivors, causing an enormous social burden. Treatments are inadequate with less than 50% of patients achieving 50% of pain relief at best, while up to 30% of cancer p ...
Voir le projet
13
Participants partenaires
TERMINÉ
Neurotrophic Cochlear Implant for Severe Hearing Loss (NeuEar)
Date du début: 1 sept. 2012, Date de fin: 31 déc. 2015,
Sixteen percent of adult Europeans suffer from hearing loss, great enough to adversely affect their daily life. Over the age of 80, 50% of the population is suffering from hearing loss. A large portion of this population is affected by sensoryneural hearing loss (SNHL), a consequence of a progressive degeneration of the primary auditory neurons (ANs), the afferent neurons of the cochlea. These ANs ...
Voir le projet
6
Participants partenaires
TERMINÉ
Innovative gene therapies for epilepsy treatment (EPIXCHANGE)
Date du début: 1 déc. 2011, Date de fin: 30 nov. 2015,
...lepsy advancing the state-of-the-art in the field. To achieve this, a strategic partnership will be created, including two internationally recognized academic institutions (UniFE, ULund) and one SME (NsGene) developing encapsulated cell biodelivery (ECB) based therapeutic products. ECBs will be transferred to the academic partners, while knowledge and technology on animal models, viral vectors and ...
Voir le projet
5
Participants partenaires
TERMINÉ
TreatPolyQ – Industrial Academic Initial Training Network towards treatment of Polyglutamine Diseases (TREATPOLYQ)
Date du début: 1 mars 2011, Date de fin: 28 févr. 2015,
Protein aggregation is a hallmark of many late onset neurodegenerative disorders including Parkinson’s Disease (PD), Alzheimer’s Disease (AD), amyotrophic lateral sclerosis (ALS), prion diseases as well as the group of polyglutamine diseases (polyQ). The aim of this proposal is to create a network of European partners bridging important basic mechanisms involved in proteinopathies, research of mod ...
Voir le projet
17
Participants partenaires
TERMINÉ
Affording Recovery In Stroke (ARISE)
Date du début: 1 mars 2008, Date de fin: 31 août 2013,
"Stroke poses a massive clinical, social and economic burden, yet we have very limited effective therapies. This inadequacy is in spite of intensive research efforts and numerous failed clinical trials. Leading European stroke researchers and clinicians with a track record of established cooperation will share their complementary expertise, and team up with SME partners with high profile R&D and o ...
Voir le projet
17
Participants partenaires
TERMINÉ
European Consortium for Stem Cell Therapy for Neurodegenerative Diseases (NEuroStemCell)
Date du début: 1 déc. 2008, Date de fin: 31 mai 2013,
The NEuroStemCell consortium will foster collaboration between leading European experimental and clinical researchers in order to maximise the prospects for successful clinical trials of stem cell therapy for Parkinson's (PD) and Huntington's (HD) Disease. The activities will be driven by a Clinical WorkPackage (WP), which will set the requirements, and monitor and guide advances in development of ...
Voir le projet